Fluticasone propionate compared with theophylline for mild-to-moderate asthma

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 2, 1996, Pages 112-118

  Galant, Stanley P ^a,b   Lawrence, Michael ^b   Meltzer, Eli O ^c   Tomasko, Marilyn ^d   Baker, Kimberly A ^e   Kellerman, Donald J ^e  

^a Pediat/Adult Allerg/Clin Immunol   (United States)

^b Allerg Asthma Med Grp and Res ^*  (United States)

^c ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^d Glaxo Research Institute   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029837804     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63496-5     Document Type: Article

References (16)

1. Laitinen LA, Heino M, Laitinen A, et al. Damage of the airway epithelial and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131: 599-606.
2. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
3. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma: National Asthma Education Program Expert Panel Report. J Allergy Clin Immunol 1991;88(3 Pt 2):425-534.
4. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990;84(Suppl A):19-23.
5. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84(Suppl A):25-9.
6. Chervinsky P, van As A, Bronsky EA, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994;94:676-83.
7. Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995;152: 1467-73.
8. Sheffer AL, LaForce C, Chervinsky P, et al. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. J Fam Prac 1996;42(4): 369-75.
9. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
10. Polgar G, Promadhar V. Pulmonary function testing in children: techniques and standards. Philadelphia: WB Saunders, 1971.
11. Statistics, in SAS User's Guide. Cary, NC, SAS Institute, vol 5, 1985; 659-64.
12. van Elterteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst 1958; 37(Part3);351-61.
13. Racineux JL, Troussier J, Tureant A. Comparison of bronchodilator effects of salbutamol and theophylline. Bull Eur Physiopathol Respir 1981;17: 799-806.
14. Jenne JW. Reassessing the therapeutic range for theophylline on laboratory report forms: another viewpoint. Pharmacotherapy 1993;13(6):595-7.
15. O'Shaughnessy KM, Gillies B, Fuller RW. Serum and urinary cortisol levels are unaltered by two weeks of inhaled fluticasone propionate [Abstract]. Am Rev Respir Dis 1993;147:A293.
16. Harding SH, Felstead S. A comparison of the tolerance and systemic effects of fluticasone propionate (FP) and beclomethasone dipropionate (BDP) in healthy volunteers [Abstract]. Eur Respir J 1988;1(Suppl 2):196S.